Produktinformation
- β-D-Glucopyranoside, (3β,12β)-12-hydroxy-20-[(O-β-D-xylopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-β-D-glucopyranosyl-
- (3β,12β)-12-Hydroxy-20-[(O-β-D-xylopyranosyl-(1→6)-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl)oxy]dammar-24-en-3-yl 2-O-β-D-glucopyranosyl-β-D-glucopyranoside
Notoginsenoside R4 is a potent compound that has been found to have antitumor properties. It is an analog of glimepiride, which is a kinase inhibitor used in the treatment of diabetes. Notoginsenoside R4 has been shown to inhibit the growth of cancer cells and induce apoptosis in tumor cells. This compound has also been found in urine samples from Chinese subjects, indicating its potential as a biomarker for cancer diagnosis. Studies have shown that notoginsenoside R4 can inhibit the activity of kinases such as apomorphine and nintedanib, which are involved in cancer cell growth and proliferation. This makes it a promising candidate for the development of new cancer therapies and inhibitors.
Chemische Eigenschaften
Technische Anfrage zu: 3D-MDA74177 Notoginsenoside R4
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
